Eli Lilly And Company Share New York Stock Exchange

The latest and trending news from around the world.

Eli Lilly and Company, Share, New York Stock Exchange
Eli Lilly and Company, Share, New York Stock Exchange from

Eli Lilly and Company

Overview

Eli Lilly and Company (NYSE: LLY) is a global health care company with a rich history of innovation and leadership in the pharmaceutical industry. Founded in 1876, the company has a long track record of discovering and developing life-changing medicines that have improved the lives of millions of people worldwide. Lilly is committed to providing innovative solutions to unmet medical needs and is dedicated to making a difference in the lives of patients.

The company's headquarters are located in Indianapolis, Indiana, and it has operations in more than 125 countries. Lilly employs approximately 35,000 people worldwide and is a Fortune 500 company. The company's mission is to improve the lives of people around the world by providing innovative medicines and solutions that address unmet medical needs.

Products and Services

Lilly's product portfolio includes a wide range of innovative medicines, including treatments for diabetes, cancer, immunology, and neuroscience. Some of the company's most well-known products include Humalog, Humulin, Trulicity, and Alimta. Lilly is also actively involved in research and development, with a pipeline of promising new medicines in various stages of development.

In addition to its pharmaceutical products, Lilly also offers a range of services to support patients and healthcare providers. These services include patient assistance programs, educational resources, and support for clinical trials. Lilly is committed to providing comprehensive care to patients and is dedicated to helping them manage their health conditions.

Financial Performance

Lilly is a financially strong company with a solid track record of growth. In 2023, the company reported revenue of $28.3 billion and net income of $6.1 billion. Lilly has a strong balance sheet with ample cash flow and a low level of debt. The company is well-positioned to continue investing in research and development and to bring new innovative medicines to market.

Corporate Responsibility

Lilly is committed to being a responsible corporate citizen. The company has a long history of supporting the communities in which it operates and is dedicated to environmental sustainability. Lilly's corporate responsibility initiatives include:

Conclusion

Eli Lilly and Company is a leading global health care company with a rich history of innovation and leadership. The company is committed to providing innovative solutions to unmet medical needs and is dedicated to making a difference in the lives of patients. Lilly is a financially strong company with a solid track record of growth and is well-positioned to continue investing in research and development and to bring new innovative medicines to market.